The risk of hyperglycemia associated with use of dolutegravir among adults living with HIV in Kampala, Uganda: A case-control study

Emerging evidence suggests a possible association between hyperglycemia and dolutegravir (DTG), a preferred first-line antiretroviral agent in sub-Saharan Africa (SSA). There is need for rigorous studies to validate this association in the face of increasing DTG use and burden of non-communicable di...

Descripción completa

Detalles Bibliográficos
Autores principales: Namara, Daphine, Schwartz, Jeremy I, Tusubira, Andrew K, McFarland, Willi, Birungi, Caroline, Semitala, Fred C, Muddu, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691558/
https://www.ncbi.nlm.nih.gov/pubmed/36222490
http://dx.doi.org/10.1177/09564624221129410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691558/
https://www.ncbi.nlm.nih.gov/pubmed/36222490
http://dx.doi.org/10.1177/09564624221129410

Ejemplares similares